Literature DB >> 14511253

Altered expression of DNA double-strand break detection and repair proteins in breast carcinomas.

S Angèle1, I Treilleux, A Brémond, P Tanière, J Hall.   

Abstract

AIMS: To determine whether the expression of DNA damage detection and repair proteins is frequently altered in breast carcinomas. METHODS AND
RESULTS: The expression profiles of five such proteins: ATM, p53, NBS1, MRE11 and Rad50 were analysed in 99 in-situ and invasive ductal breast carcinomas of different grades using an immunohistochemical approach, and compared with those seen in eight independent non-cancer (normal) breast samples and in the surrounding normal tissues of the breast carcinomas examined. ATM protein expression was reduced in 75% of the tumours compared with the levels found in normal tissues. Fewer tumours had reduced protein levels of the members of the MRE11, NBS1 and Rad50 (MNR) complex (31%, 46% and 28%, respectively) with p53 being over-expressed in 30%. In the majority of tumours (92%) we observed a good correlation between the expression of the three proteins of the MNR complex with low NBS1, MRE11 or Rad50 expression rarely found alone, suggesting that this event occurs subsequently to the deregulation in expression of other DNA repair proteins.
CONCLUSION: The pattern of protein changes observed supports our hypothesis that alterations in DNA double-strand break repair capacity are involved in mammary carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511253     DOI: 10.1046/j.1365-2559.2003.01713.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  12 in total

1.  Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients.

Authors:  Mahdieh Salimi; Hossein Mozdarani; Keivan Majidzadeh
Journal:  Med Oncol       Date:  2011-08-18       Impact factor: 3.064

2.  An immunohistochemical panel to assess ultraviolet radiation-associated oxidative skin injury.

Authors:  A Mamalis; N Fiadorchanka; L Adams; M Serravallo; E Heilman; D Siegel; N Brody; J Jagdeo
Journal:  J Drugs Dermatol       Date:  2014-05       Impact factor: 2.114

3.  Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.

Authors:  Jirina Bartkova; Johanna Tommiska; Lenka Oplustilova; Kirsimari Aaltonen; Anitta Tamminen; Tuomas Heikkinen; Martin Mistrik; Kristiina Aittomäki; Carl Blomqvist; Päivi Heikkilä; Jiri Lukas; Heli Nevanlinna; Jiri Bartek
Journal:  Mol Oncol       Date:  2008-10-07       Impact factor: 6.603

4.  DNA protein kinase-dependent G2 checkpoint revealed following knockdown of ataxia-telangiectasia mutated in human mammary epithelial cells.

Authors:  Sonnet J H Arlander; Bryan T Greene; Cynthia L Innes; Richard S Paules
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

5.  Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.

Authors:  Zi-Zhen Zhang; Yuan Jie Charles Liu; Xiao-Lu Yin; Ping Zhan; Yi Gu; Xing-Zhi Ni
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

6.  WSB1 overcomes oncogene-induced senescence by targeting ATM for degradation.

Authors:  Jung Jin Kim; Seung Baek Lee; Sang-Yeop Yi; Sang-Ah Han; Sun-Hyun Kim; Jong-Min Lee; Seo-Yun Tong; Ping Yin; Bowen Gao; Jun Zhang; Zhenkun Lou
Journal:  Cell Res       Date:  2016-12-13       Impact factor: 25.617

7.  RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy.

Authors:  Ali Flores-Pérez; Lourdes E Rafaelli; Nayeli Ramírez-Torres; Elena Aréchaga-Ocampo; Sara Frías; Silvia Sánchez; Laurence A Marchat; Alfredo Hidalgo-Miranda; Valeria Quintanar-Jurado; Sergio Rodríguez-Cuevas; Verónica Bautista-Piña; Angeles Carlos-Reyes; César López-Camarillo
Journal:  Cancer Biol Ther       Date:  2014-03-18       Impact factor: 4.742

8.  Tumor protein D52 represents a negative regulator of ATM protein levels.

Authors:  Yuyan Chen; Alvin Kamili; Jayne R Hardy; Guy E Groblewski; Kum Kum Khanna; Jennifer A Byrne
Journal:  Cell Cycle       Date:  2013-08-21       Impact factor: 4.534

9.  Expression of ATM, p53, and the MRE11-Rad50-NBS1 complex in myoepithelial cells from benign and malignant proliferations of the breast.

Authors:  S Angèle; C Jones; J S Reis Filho; L G Fulford; I Treilleux; S R Lakhani; J Hall
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

10.  XRCC3 and RAD51 expression are associated with clinical factors in breast cancer.

Authors:  Jia Hu; Ning Wang; Ya-Jie Wang
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.